Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 1Muscle Invasive Bladder Carcinoma 1Muscle Invasive Bladder Cancer 1HER2 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

toripalimab 1tislelizumab 1liposomal doxorubicin 1disitamab vedotin 1RC48 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Muscle Invasive Bladder Cancer × disitamab vedotin × Clear all
NCT05979740 2023-08-31

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

RenJi Hospital

Phase 2 Unknown
6 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡